G01N 2333/96411
Serine endopeptidases
Official title: Serine endopeptidases (3.4.21)
G01N2333/96411 (Serine endopeptidases) appears on 27 US grants and 62 published applications in this corpus.
Search patents in G01N- Granted patents
- 27
- Published applications
- 62
- Assignees
- 38
- Inventors
- 125
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 2 |
| 2011 | 0 | 2 |
| 2012 | 1 | 2 |
| 2013 | 1 | 0 |
| 2014 | 0 | 2 |
| 2015 | 2 | 2 |
| 2016 | 0 | 3 |
| 2017 | 0 | 3 |
| 2018 | 3 | 6 |
| 2019 | 1 | 3 |
| 2020 | 2 | 5 |
| 2021 | 2 | 4 |
| 2022 | 3 | 6 |
| 2023 | 5 | 5 |
| 2024 | 3 | 6 |
| 2025 | 0 | 6 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for producing an exdotoxin measuring agent29 Sep 2026US 12,748,115 B2Seikagaku Corporation
- Recombinant amebocyte lysate and uses thereof3 Dec 2024US 12,158,471 B2Charles River Laboratories, Inc.
- Recombinant Factor C and method for producing the same, and method for measuring endotoxin16 Apr 2024US 11,959,109 B2Seikagaku Corporation
- Fibroblast activation protein (FAP) targeted imaging and therapy in fibrosis6 Feb 2024US 11,890,357 B2Purdue Research Foundation
- Methods for quantifying drug concentration in a prodrug composition24 Oct 2023US 11,796,546 B2Genzyme Corporation
- Method for producing recombinant horseshoe crab factor, endotoxin assay agent, and method for producing endotoxin assay agent23 Jul 2026US 2026/0209738 A1Seikagaku Corporation
- An analytical method using lc-ms/ms proteomics to characterize proteins translated from mrna16 Apr 2026US 2026/0104425 A1Merck Sharp & Dohme Corp.
- Biomarkers8 Jan 2026US 2026/0009802 A1Oxford University Innovation Limited
- Spatially identifying nucleic acids that interact with proteins17 Jul 2025US 2025/0230498 A1
- Novel recombinant factor c and method for producing the same, and method for measuring endotoxin29 May 2025US 2025/0171759 A1Seikagaku Corporation
Most cited
By later US patents
- Treatment of chronic pelvic pain syndrome15US 8,586,044 B2Northwestern University · 2013
- Treatment of chronic pelvic pain syndrome11US 9,181,577 B2Northwestern University · 2015
- Recombinant Factor C and method for producing the same, and method for measuring endotoxin3US 10,144,923 B2Seikagaku Corporation · 2018
- Recombinant Factor C and method for producing the same, and method for measuring endotoxin3US 11,236,318 B2Seikagaku Corporation · 2022
- Calibrator and use thereof in an immunoassay3US 5,759,858 AAkzo Nobel N. V. · 1998